Imposed faster and slower walking speeds influence gait stability differently in Parkinson fallers by Cole, Michael H. et al.
Running Head: Speed-related changes in gait stability 
 
Title: Imposed faster and slower walking speeds influence gait stability 
differently in Parkinson fallers 
 
Authors: Michael H. Cole Ph.D.1, Matthew Sweeney Ph.D.1, Zachary J. Conway 
B.Sc. (Hons)1, Tim Blackmore Ph.D.1,2, Peter A. Silburn Ph.D., FRACP3 
 
Affiliations: 1. Australian Catholic University, School of Exercise Science, Banyo, 
Queensland, AUSTRALIA 
 2. University of Portsmouth, Department of Sport & Exercise Science, 
Hampshire, United Kingdom 
 3. Asia-Pacific Centre for Neuromodulation, Queensland Brain Institute, 
The University of Queensland, Brisbane, Queensland, AUSTRALIA 
 
Study Location: Australian Catholic University, School of Exercise Science, Banyo, 
Queensland, AUSTRALIA 
 
Word Count: 2994 words (Introduction to Discussion) 
 
Submission Type:  Original Research 
 
Competing Interests: The authors declare no competing interests 
 
Presented at:    20th International Parkinson’s Disease and Movement Disorders 
Society Congress, Berlin, June 19-23, 2016 (Poster Format) 
 Financial Disclosure 
This study was supported by a Faculty of Health Sciences Research Grant provided by the 
Australian Catholic University. Dr Michael H. Cole was supported by an Australian National 
Health and Medical Research Council (NHMRC) Early Career Researcher Fellowship (Project 
#GNT1016481) and research funding provided by the Australian Catholic University (Project 
#2013000570). The funding bodies did not contribute to data collection or data analysis and 
played no part in the decision to prepare and publish this manuscript. 
 
Acknowledgements 
The authors would also like to thank Ms Majella Hales for her assistance with data collection 
during the treadmill validation trial and those people with Parkinson’s disease and the age-
matched controls who gave so generously of their time to help make this research possible. 
This study was supported by funding awarded by the Faculty of Health Sciences at the 
Australian Catholic University and Dr Cole was supported by an Australian National Health 
and Medical Research Council Early Career Researcher Fellowship (Project #GNT1016481) 
and research funding awarded by the Australian Catholic University (Project #2013000570). 
 
Correspondence: Dr Michael H. Cole   
 School of Exercise Science  
 Australian Catholic University  
 P.O. Box 456    
 Virginia, Queensland, 4014  
 AUSTRALIA  
Email Address:  michael.cole@acu.edu.au   
Telephone: +61 7 3623 7674 
Highlights 
 Parkinson’s patients with a falls history had poorer rhythmicity at all gait speeds 
 Improvements in walking speed do not necessarily imply improved postural stability 
 Combining gait retraining with other therapies may benefit high-risk Parkinson’s patients 
 ABSTRACT 
Objective: This cross-sectional study sought to evaluate the effect of imposed faster and 
slower walking speeds on postural stability in people with Parkinson’s disease (PD). 
 
Design: Cross-sectional cohort study 
 
Setting: General community 
 
Participants: 84 PD patients (51 with a falls history; 33 without) and 82 age-matched 
controls were invited to participate via neurology clinics and pre-existing databases.  Of those 
contacted, 99 did not respond (PD=36; controls=63) and 27 were not interested (PD=18; 
controls=9). Following screening, a further 10 patients were excluded; 5 had deep brain 
stimulation surgery and 5 could not accommodate to the treadmill. The remaining 30 patients 
completed all assessments and were sub-divided in PD fallers (n=10), PD Non-Fallers (n=10) 
and age-matched controls (n=10) based on falls history. 
 
Protocol: Symptom severity, balance confidence and medical history were established prior 
to participants walking on a treadmill at 70%, 100% and 130% of their preferred speed.  
 
Main Outcomes: Three-dimensional accelerometers assessed head and trunk accelerations 
and allowed calculation of harmonic ratios (HRs) and root mean square (RMS) accelerations 
to assess segment control and movement amplitude. 
 
Results: Head and trunk control was lower for PD Fallers than PD Non-Fallers and Older 
Adults. Significant interactions indicated head and trunk control increased with speed for PD 
 Non-Fallers and Older Adults, but did not improve at faster speeds for PD Fallers. Vertical 
head and trunk accelerations increased with walking speed for PD Non-Fallers and Older 
Adults, while the PD Fallers demonstrated greater anteroposterior RMS accelerations 
compared with both other groups. 
 
Conclusion: The results suggest that improved gait dynamics do not necessarily represent 
improved walking stability and this must be respected when rehabilitating gait in PD patients. 
 
Keywords: Gait; Segmental Control; Harmonic Ratio; Parkinson Disease; Falls  
 Parkinson’s disease (PD) is a debilitating neurodegenerative condition that is characterised by 
motor symptoms that include resting tremor1, slowness of movement2, muscle rigidity2, 
postural instability2, and gait disturbances (e.g. freezing of gait (FOG))1. Unfortunately, 
symptoms of postural instability and gait disability are only partially responsive to current 
pharmacological interventions3. In fact, research shows that, even when optimally-medicated, 
people with PD demonstrate more asymmetric movement patterns4, 5, walk more slowly6-9, take 
shorter strides6-9 and have less rhythmic acceleration profiles for the head10 and trunk11 
compared with age-matched controls. The changes in segmental rhythmicity appear to be 
related, at least in part, to deficits in neuromuscular control12 and seem to be more prominent 
in people with PD who prospectively report falls13, 14.  Given this apparent relationship 
between postural instability, gait disability and falls in people with PD and the obvious 
ineptitude of current pharmacological therapies, clinicians and scientists have sought to identify 
suitable alternatives to manage these symptoms. 
 
Treadmill-based gait retraining that incorporates auditory or visual cues has emerged as a 
common form of physical therapy and seeks to correct gait impairments in people with PD by 
increasing their stride length and, ultimately, their walking speed15. Importantly, the existing 
literature concerning gait retraining indicates that this form of therapy succeeds at this goal 
by helping patients to increase their stride length16-21, walking speed17-23 and walking 
distance22. Despite the established benefits of treadmill-based gait retraining for people with 
PD, the precise relationships between changes in walking speed and walking stability and/or 
falls risk are far less clear. For example, some prospective research has demonstrated that 
community-dwelling older adults who walk at slower (<0.6 m/s) or faster (≥1.3 m/s) speeds 
are at an increased risk of future falls24. Similar results were presented in a cross-sectional 
study involving healthy younger adults, which showed that slower and faster than preferred 
 speeds led to sub-optimal walking stability25.  However, despite these findings, a series of 
studies adopting non-linear analyses have suggested that local dynamic stability is 
significantly improved at slower walking speeds for healthy younger adults26, 27, older 
adults28 and patients with significant peripheral neuropathy29, 30.  Given these conflicting 
results, it remains unclear whether the slower walking speeds adopted by people with PD 
serve to optimise their dynamic stability or contribute to their increased risk of falling. An 
improved understanding of this relationship would help clinicians to better appreciate how 
changes to a patient’s walking speed might influence their stability and overall risk of falls.  
 
During dynamic tasks, the maintenance of equilibrium relies upon one’s capacity to control 
the movements of the head and trunk, which represent almost 60% of the body’s mass31, 32. 
From a functional perspective, the head is considered an important natural frame of reference, 
as it houses the organs responsible for the visual and vestibular information used in postural 
control and orientation33-35. The trunk is also believed to play a role in maintaining postural 
stability during locomotion, as it serves to attenuate movement-related forces that project 
upwards from the feet and threaten to destabilise the head36, 37. However, research reporting 
larger12-14 and less rhythmic10, 11 head and trunk movements for people with PD provides 
evidence to suggest that this population may have an impaired capacity to attenuate these 
forces. Support for this notion was recently provided in a study that demonstrated people with 
PD have an impaired capacity to attenuate accelerations from the pelvis and neck to the 
head38. This impairment is likely related to the increased axial rigidity that is evident in 
people with PD during standing39 and walking40, which is seemingly caused by differences in 
the activation patterns of the paraspinal muscles in this population12.  While it is widely 
recognised that the routine use of anti-parkinsonian medication can significantly improve 
some characteristics of gait41, 42, it is equally well-documented that the symptoms of axial 
 rigidity that contribute to postural instability and falls in this population are not well managed 
with traditional therapies40, 43.  Given this situation, there appears to be a clear need for 
research aimed at elucidating whether increasing walking speed in people with PD can be 
achieved without inadvertently influencing postural stability. As such, it was the purpose of 
this study to determine whether walking at speeds faster or slower than preferred reduces 
postural stability for people with PD.  Given that slower and faster walking speeds have been 
linked with a greater risk of falls in older adults24, it was hypothesised that walking at speeds 
other than one’s preferred walking speed would reduce postural stability and that this 
relationship would be more pronounced for participants with a history of falling. 
 
METHODS 
Study Population 
Between August and November 2014, 84 people clinically-diagnosed with idiopathic PD 
based on the Parkinson’s United Kingdom Brain Bank Criteria44 were invited to participate 
via community support groups and neurology clinics.  Over the same period, 82 age-matched 
older adults (Controls) from the Brisbane metropolitan area were contacted via an existing 
database of individuals who had expressed interest in contributing to research of this nature. 
Of those contacted, 99 did not respond (PD=36; Controls=63) and 27 were not interested 
(PD=18; Controls=9). The remaining 30 people with PD and 10 controls were screened and 
excluded if they had; i) recently undergone surgery; ii) a recurrent history of musculoskeletal 
injury; iii) an inability to walk without assistance; iv) significant visual (Bailey-Lovie high 
contrast visual acuity >0.30 logMAR) or cognitive (Addenbrooke’s Cognitive Examination 
score <82 out of 10045) impairment; or v) received deep brain stimulation. Following 
screening, 5 patients were excluded as they had received deep brain stimulation and 5 were 
excluded as they were unable to accommodate to the treadmill.  The remaining participants 
 reported the number of falls that they had experienced in the past year and these data were 
used to separate PD Fallers (n=10) from PD Non-Fallers (n=10) and Older Adults (n=10). In 
all cases, the PD Fallers attributed their falls directly to complications associated with the 
symptoms and/or treatment of their condition (e.g. freezing of gait; festination, retropulsion; 
postural instability), rather than to situations that might be considered typical for an otherwise 
healthy individual. Falls were assessed retrospectively and defined as any unintentional 
coming to the ground or some lower level not as a result of a major intrinsic event or 
overwhelming hazard46. 
 
An a-priori power calculation performed using data presented previously11 indicated that a 
sample size of 10 participants per group was sufficient to detect any significant changes in 
dynamic stability (diff = 0.05, SD = 0.04, Cohen’s d = 1.25, Power = 80%, p = 0.05). The 
experimental protocol was approved by the Human Research Ethics Committee at the 
Australian Catholic University and, in accordance with the Declaration of Helsinki, all 
participants gave written informed consent prior to participating in this research. 
 
INSERT TABLE 1 ABOUT HERE 
 
Clinical Assessment 
Prior to the gait assessment, details related to each participant’s falls history, medical history 
and current medications were collected via a brief health questionnaire, while balance 
confidence was assessed using the 6-item Activities-specific Balance Confidence scale47. 
Additionally, an experienced movement disorders researcher completed clinical assessments 
for the PD participants to establish each patient’s symptom severity and quality life. 
Specifically, symptom severity was assessed using the motor sub-scale of the Unified 
 Parkinson’s Disease Rating Scale (UPDRS III)48, the Hoehn and Yahr stage score49 and the 
Schwab and England Activities of Daily Living (ADL) scale50.  Additionally, FOG and 
quality of life were assessed using the Revised Freezing of Gait questionnaire51 and the 8-
item Parkinson’s Disease Questionnaire52, respectively.  By calculating the sum of the scores 
for the items relating to rigidity on the UPDRS III, a global rigidity score was determined 
using previously-described methods53. All procedures were completed while the PD patients 
were receiving their usual anti-parkinsonian treatment, with 10 PD Fallers (100%) and 9 PD 
Non-Fallers (90%) being treated with levodopa and/or dopamine agonists (Table 1). 
 
Apparatus 
Two wireless 6g microelectromechanical systems (MEMS) tri-axial accelerometers (Noraxon 
Inc., USA) were positioned over the occipital protuberance of the skull and the spinous 
process of the 10th thoracic vertebra to measure head and trunk accelerations during treadmill 
walking.  The head accelerometer was attached to a firm-fitting headband, while the trunk 
accelerometer was firmly affixed to the skin using double-sided tape and Omnifix.  Head and 
trunk accelerations were sampled at 1500 Hz and telemetered wirelessly to a Telemyo DTS 
receiver connected to a laptop running the MyoResearch XP software (v1.08, Noraxon Inc., 
USA). Prior to attaching the equipment, a series of static trials were completed while each of 
the accelerometers’ axes were perpendicularly aligned with a horizontal surface to measure 
gravitational acceleration (1 gravitational unit or 1g) in the absence of movement54. 
 
The walking trials were completed on a Quasar motorised treadmill (HP Cosmos, DE) that 
had a moving surface size of 1.70 x 0.65 m (L x W) and an overhead safety frame fitted to 
facilitate anchoring of the participant safety harness. To ensure that participants were blind to 
their walking speed and to any changes that were made throughout the testing period, the user 
 terminal was rotated such that the participants were unable to see the electronic display. Prior 
to data collection, the validity of the treadmill’s belt speed was assessed using a three-
dimensional motion analysis system (T-Series cameras with Nexus 1.7; Vicon, UK) and was 
found to be accurate under both loaded and unloaded conditions at speeds ranging from 0.6 to 
2.0 m/s (mean error = ±0.03 m/s). 
 
Data Collection 
To ensure that they could safely ambulate on the treadmill, each participant completed a 
familiarisation period while wearing their own comfortable walking shoes and a safety vest 
that was attached to the overhead safety frame.  Each participant’s preferred walking speed 
was then determined during three independent trials that were each separated by a rest break 
of no less than 60 seconds. During these trials, the treadmill’s speed was systematically 
increased or decreased in 0.1 m/s increments based on the participant’s instruction until they 
reported that they were walking at a comfortable speed. The average walking speed for these 
three trials was considered to be representative of the participant’s preferred walking speed 
(100%) and was used to calculate the slower (70%) and faster (130%) walking conditions26. 
Using this information, participants completed a graded walking task that involved walking 
on the treadmill for 60 seconds at intensities that were equal to 70%, 100% and 130% of their 
preferred walking speed. To ensure that the acceleration/deceleration phase of each trial did 
not influence the reported outcomes, each 60-second data collection period did not 
commence until the treadmill had reached the target velocity and the participants reported 
having achieved a steady walking pattern.  Given people with PD experience greater 
symptoms of gait impairment13, 14 and fear of falling55, the order of walking speeds (Intensity) 
was progressed from slowest to fastest. Furthermore, to limit the potential influence of 
fatigue, each walking trial was separated by a mandatory 1-minute rest break.  
  
Data Analysis 
Following data collection, the raw three-dimensional head and trunk accelerations were 
transformed to a horizontal-vertical orthogonal coordinate system using an extrapolation of 
simple trigonometry36.  In short, transformation of the accelerations was required to correct 
for tilt in the AP and ML directions, such that the accelerometer’s vertical axis was realigned 
with the gravity vector (i.e. global vertical axis)56. The transformation algorithm achieved this 
by assuming that the head and trunk accelerometers were rotated (i.e. r(theta1, theta2)) and 
that this angle was constant throughout the trial. This assumption was guided by previous 
research, which reported that the orientation of the upper body changes minimally during 
gait57, 58 and, hence would only influence gait-related accelerations to a small degree36, 59. 
During pilot testing, the performance of the transformation process was assessed by 
comparing the transformed accelerations from the Noraxon system with data simultaneously 
collected using XSens inertial measurement units (IMUs). Data from the IMUs were rotated 
using the device’s internal gyroscope and comparison of the anteroposterior (AP), 
mediolateral (ML) and vertical (VT) acceleration profiles from the two systems returned 
correlation coefficients of 0.8 or greater for all three axes.  Following transformation, the 
timing of individual foot contacts was identified via the recurring peaks in the vertical trunk 
acceleration profile11, 60, 61 and used to crop each trial to a length that included 10 left and 10 
right gait cycles (i.e. 20 gait cycles total). The cropped data were then low-pass filtered using 
a fourth-order Butterworth filter with a cut-off frequency of 30 Hz59, 62.  
 
To examine changes in the rhythmicity of AP, ML and VT head and trunk accelerations at 
the different walking speeds, the harmonic ratio (HR) was calculated by firstly dividing the 
continuous data series into individual gait cycles (i.e. 20 per trial). Data for each gait cycle 
 were then converted to the frequency domain using the Fast Fourier Transformation, which 
allowed the harmonics of the signal’s fundamental frequency (i.e. stride frequency63) to be 
identified64.  As each gait cycle is comprised of two steps, the AP and VT acceleration 
profiles of a healthy individual are typically characterised by two comparable peaks25.  As 
these peaks repeat in multiples of two, the frequency spectra of AP and VT accelerations are 
dominated by the even harmonics (i.e. 2, 4), which represent the in-phase component of these 
signals. In contrast, ML accelerations are characterised by two opposing peaks; 1 
corresponding with a weight shift to the left leg and 1 corresponding with a weight shift to 
the right leg. This unique characteristic of the ML acceleration profile means that the odd 
harmonics (i.e. 1, 3) dominate this component and, hence represent the in-phase component 
of this signal. Using the first 20 harmonics for each gait cycle (i.e. 10 in-phase; 10 out-of-
phase), the AP, ML and VT harmonic ratios were calculated for the head and trunk by 
dividing the sum of the in-phase harmonics by the sum of the out-of-phase harmonics64. 
Given this calculation, larger HRs represent a greater proportion of in-phase accelerations 
relative to out-of-phase accelerations, which is indicative of greater movement rhythmicity 
and poorer segmental control64, 65. 
 
To provide insight into the amplitude of head and trunk accelerations during the walking task, 
the root mean square (RMS) amplitude of the time-series data for the AP, ML and VT 
accelerations was also calculated66.  In addition to the three-dimensional HRs and RMS 
accelerations, the timings of each individual foot contact were used to calculate a number of 
spatiotemporal characteristics. Specifically, cadence (steps/min) was assessed by determining 
the number of steps taken by each participant during the 60-second trial, while stride timing 
variability (ms) was derived by calculating the standard deviation of the time taken by the 
participant to complete each of the 20 gait cycles (i.e. stride time)67, 68.  Lastly, given that 
 walking speed is a composite measure representing stride length (i.e. distance) divided by 
stride time, stride length was calculated by multiplying walking speed (m/s) by stride time. 
These outcome measures were selected as they have been extensively used to assess walking 
in people with PD11, 65, 69 and have been previously shown to discriminate retrospective fallers 
from non-fallers in this population10. All processing of the raw head and trunk accelerations 
was performed using a custom Matlab program (R2015b, The MathWorks, USA). 
 
Statistical Analysis 
A one-way analysis of variance (ANOVA) was used to compare the groups for differences in 
demographics, falls history, fear of falling, quality of life and symptom severity. When a 
significant main effect was identified, the Tukey’s Honestly Significant Difference (HSD) 
post-hoc test was used to determine where the statistically significant differences existed. 
When the assumptions of ANOVA were violated, the non-parametric Kruskal-Wallis Test 
was used to compare the groups, while the degree of association between categorical 
variables was assessed using the chi-square (χ2) test.  
 
To determine mean differences between the PD Fallers, PD Non-Fallers and Older Adults for 
the accelerometer-based measures of gait rhythmicity and segmental motion, linear mixed 
model (LMM) analyses with one repeated (Intensity, 3 levels) and one fixed (group, 3 levels) 
factor were used. As gait speed and stride time variability both influence segmental 
accelerations10, both were entered as covariates for the analysis of HRs and RMS 
accelerations.  Furthermore, to determine whether differences in disease duration, symptom 
severity and/or medication use accounted for any differences in HRs or RMS accelerations, a 
series of sub-analyses were conducted for the PD Fallers and Non-Fallers, with these clinical 
scores also entered as covariates. Where significant main effects or interactions were 
 identified, Tukey’s Least Significant Difference post-hoc tests were used to conduct pairwise 
comparisons between the groups. All statistical procedures were conducted using SPSS v.22 
and the level of significance was set at p < 0.05. 
 
RESULTS 
Demographics and Clinical Assessments 
PD Fallers, PD Non-Fallers and Older Adults did not differ significantly with respect to age, 
gender distribution, height or mass, but PD Fallers had increased rigidity, poorer quality of 
life and greater symptom severity than patients in the PD Non-Faller group. PD Fallers also 
tended to report poorer balance confidence than the other participants (p=0.08) and to be 
taking larger daily doses of levodopa than PD Non-Fallers (p=0.06); however, these trends 
did not achieve statistical significance. Similarly, the PD Faller and Non-Faller groups were 
not different with respect to disease duration or the proportion of patients prescribed 
dopamine agonists, catechol-o-methyl transferase (COMT) inhibitors, monoamine oxidase 
inhibitors (MAOIs) and/or benzodiazepines (Table 1). 
 
Walking Assessment 
PD Fallers walked significantly slower and took significantly shorter strides, but did not 
differ from the PD Non-Fallers or Older Adults with respect to cadence and stride time 
variability. Significant main effects for Intensity indicated that stride length and cadence 
systematically increased from the 70% to 100% to 130% conditions, while stride time 
variability systematically decreased as walking speed increased (Figure 1). With respect to 
head and trunk rhythmicity, significant main effects for Intensity indicated that harmonic 
ratios were significantly reduced (poorer) during the 70% trials compared with the 100% and 
130% conditions. Furthermore, ML head and trunk rhythmicity was significantly improved 
 when participants walked at the 130% walking speed compared with their preferred walking 
speed (100%). Significant main effects for Group were reported for the ML and VT axes of 
head and the AP, ML and VT axes of the trunk. Post-hoc analyses revealed that PD Non-
Fallers recorded significantly lower head (ML, VT) and trunk (AP, ML, VT) rhythmicity than 
the Older Adults (Figure 2). Similarly, PD Fallers had significantly lower head (ML, VT) and 
trunk (AP, ML, VT) harmonic ratios than PD Non-Fallers and Older Adults and sub-analysis 
of the PD Fallers and Non-Fallers suggested that these findings were not attributable to 
differences in disease duration, symptom severity and/or daily levodopa equivalent dose.  
 
INSERT FIGURE 1 ABOUT HERE 
 
In addition to these main effects, significant Group*Intensity interactions were reported for 
AP and VT harmonic ratios for the head and AP, ML and VT harmonic ratios for the trunk. 
Further examination of these interactions showed that the speed-related changes in head and 
trunk rhythmicity for PD Fallers were significantly different to those observed for PD Non-
Fallers and Older Adults. Specifically, head AP and VT harmonic ratios for the PD Non-
Fallers and Older Adults significantly increased as walking speed increased. An improvement 
in AP and VT head rhythmicity between the 70% and 100% walking speeds was also evident 
for the PD Fallers, but AP head rhythmicity was unchanged between the 100% and 130% 
conditions, while VT head rhythmicity declined at the faster speed. Similarly, AP, ML and 
VT trunk harmonic ratios remained unchanged or improved as walking speed increased for 
the PD Non-Fallers and Older Adults, while both AP and VT trunk harmonic ratios were 
significant reduced for the PD Fallers during the 130% walking trial, compared with the 
100% condition (Table 2).  
 
 INSERT FIGURES 2 AND 3 ABOUT HERE 
 
The RMS accelerations demonstrated that PD Fallers had significantly greater AP head 
accelerations than PD Non-Fallers and Older Adults, but were not dissimilar with respect to 
any other component of head or trunk acceleration. The sub-analyses conducted for the two 
PD groups indicated that the larger RMS head accelerations (AP) recorded for the PD Fallers 
were largely explained by differences in disease duration, symptom severity and/or levodopa 
daily equivalent doses. Significant main effects for Intensity suggested that AP and ML head 
accelerations and ML trunk accelerations were significantly greater during the 70% condition 
relative to the 100% and 130% walking trials (Figure 3). In contrast, VT RMS accelerations 
for the head and trunk were significantly greater during the 130% condition compared with 
the 70% and 100% conditions. Significant Group*Intensity interactions for VT head and 
trunk accelerations indicated that VT acceleration amplitudes were consistent for the PD 
Fallers across the walking speeds, but were significantly increased at the fastest speed for PD 
Non-Fallers and Older Adults. Furthermore, the significant Group*Intensity interaction for 
AP RMS accelerations indicated that PD fallers had significantly greater head accelerations at 
the slowest walking speed compared with the 100% and 130% conditions (Table 2). 
 
INSERT TABLE 2 ABOUT HERE. 
 
DISCUSSION 
The results of this cross-sectional study only partially supported our hypothesis that walking 
at speeds slower and faster than preferred would correspond with poorer head and trunk 
rhythmicities. As hypothesised, poorer stability was observed for all participant groups at 
walking speeds that were slower than preferred, but as walking speed increased, head and 
 trunk rhythmicity generally improved as well. These findings are in contrast to previous 
research involving healthy younger adults, which showed that pelvic and, to a lesser extent, 
head rhythmicities were optimal when participants walked at their preferred speed, but 
declined at faster and slower speeds25. Similarly, the results of a longitudinal study indicated 
that the risk of falling was significantly greater in older adults who walked slower (<0.6 m/s) 
or faster (≥1.3 m/s)24, suggesting that stability may be optimised at specific movement 
speeds. The disparity between the results of the current study and those presented in this 
earlier research may be explained by differences in the coordination and variability of 
segmental motion during treadmill and overground walking. For example, research shows 
that individuals exhibit reduced variability in their stride-to-stride gait patterns and joint 
kinematics during treadmill walking compared with overground gait70, 71.  Such differences 
are argued to be due to the relatively fewer task constraints imposed by overground walking, 
which ultimately gives individuals a greater number of performance options that are equally 
appropriate for achieving the desired outcome71, 72. Interestingly, the results of this study also 
showed that stride timing variability systematically decreased from the slowest to the fastest 
walking speed, while separate research examining overground walking in younger adults 
reported increased stride time variability at speeds slower and faster than preferred73. 
Considering that the harmonic ratio provides a measure of the in-phase to out-of-phase 
segmental accelerations, it is possible that the improved stability demonstrated by the 
participants at the faster speed was reflective of the less variable walking patterns recorded 
for these individuals during this condition. 
 
Despite the results tending to suggest that increased walking speeds lead to improved head 
and trunk stability in older adults and people with PD, the post-hoc analyses indicated that 
head and trunk accelerations either remained unchanged or decreased at the faster walking 
 speed for PD Fallers.  Considering this finding with the overall deficits in head and trunk 
control and the increased AP head accelerations that were evident for the PD Fallers, it seems 
that these individuals may have a reduced capacity to control these larger segments, which 
would directly impact their postural stability. These results are in agreement with previous 
research showing that people with PD have significantly greater AP and ML head 
accelerations than healthy younger and older adults, which are likely to influence their 
capacity to recover from a perturbation74.  Collectively, these finding suggest that while some 
patients (e.g. PD Non-Fallers) may have the capacity to adapt to the changing demands of a 
task, patients who have a history of falls and typically walk at slower preferred speeds may 
not. A possible explanation as to why the PD Fallers demonstrated different patterns of head 
and trunk control at the faster walking speed might be found in the higher global rigidity 
scores reported for these patients at baseline. According to previous research, the rigidity of 
the axial system (e.g. trunk, pelvis, neck) significantly increases at faster walking speeds for 
people with PD40.  Given the axial skeleton essentially serves as a biological shock absorber 
to minimise the effects of movement-related forces on the visual and vestibular systems33-36, 
an increase in the rigidity of this system would likely influence its capacity to perform this 
role. As such, the higher prevalence of rigidity evident in the PD fallers may have made these 
individuals more susceptible to speed-related changes in axial rigidity and account for a 
plateau or decline in head and trunk stability during the faster walking trials. Nevertheless, 
the significant decline in some aspects of dynamic stability at the faster walking speed 
suggests that the assessment of gait during fast-paced walking may be more suitable for 
identifying people with PD who are at an increased risk of falling75.  Furthermore, it seems 
that if therapists are not monitoring changes in postural stability during gait retraining 
programs, it is possible that improvements in gait dynamics may come at the cost of an 
increased falls risk for some patients. 
  
Study Limitations 
There are a number of methodological factors that should be considered when reviewing our 
results, as they have the potential to limit our capacity to directly compare our findings with 
previous research.  First, we elected to conduct our assessments on a motorised treadmill to 
strictly control changes in walking speed and to ensure the safety of the participants. 
However, previous research has shown that treadmill walking is not a perfect analogue for 
overground walking, as it generally returns different values for some spatiotemporal 
characteristics76, 77, gait variability71, 77 and joint kinetics76, 78.  Second, the use of tri-axial 
accelerometers to assess head and trunk rhythmicity during the walking trials limited our 
capacity to objectively evaluate other factors that may potentially have influenced gait 
stability (e.g. arm swing, base of support). Although there is a growing body of evidence to 
suggest that the size of one’s base of support is not significantly influenced by their walking 
speed79-81, research has consistently reported a relationship between arm swing and walking 
speed in healthy younger82 and older adults83.  While it remains unclear whether arm swing 
directly influences walking stability84 or whether it serves to recover a stable walking pattern 
following a perturbation85, it is important to acknowledge that differences in arm swing 
between the groups may have potentially impacted the reported outcomes. Future research 
should seek to determine the specific role(s) of arm swing in stabilising the gait patterns of 
people with PD and evaluate whether imposed faster and slower walking speeds influence 
walking stability in a similar way during overground walking in this population. Despite the 
shortcomings of this methodological approach, our findings are likely to be of significant 
clinical relevance, as physical therapists are often restricted to using treadmills for gait 
retraining due to space limitations and the need to minimise patient risk in the clinical setting. 
Furthermore, if we consider that those patients who are most likely to be referred to physical 
 therapists for gait retraining are those who present with significant gait disability that limits 
their walking speed, then these findings have obvious implications for current practice. 
 
CONCLUSIONS 
While systematic evidence indicates that gait retraining can improve stride length16-21, 
walking speed17-23 and walking distance22 in people with PD, the results of this study suggest 
that these changes may lead to an increased risk of future falls for some patients if postural 
stability is not targeted. As such, we recommend that gait retraining should not be 
implemented as a stand-alone therapy for high-risk PD patients, but rather should be coupled 
with other physical therapy that seeks to address any underlying balance impairments that 
may be present for an individual.  
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 FIGURE LEGENDS 
Fig. 1: Mean (+1 SD) walking speeds, stride lengths, cadences and stride time variability for 
the PD fallers, PD Non-Fallers and age-matched Older Adults while walking on the treadmill 
at 70%, 100% and 130% of their preferred walking speed. 
 
Fig. 2: Estimated Marginal Means (EMM) and standard errors (SE) for the head and trunk 
harmonic ratios (adjusted for walking speed and stride time variability) for the PD fallers, PD 
Non-Fallers and Older Adults while walking on the treadmill at 70%, 100% and 130% of 
their preferred walking speed. Note: Larger harmonic ratios depict a greater proportion of in-
phase relative to out-of-phase accelerations and, hence represent more stable gait patterns. 
 
Fig. 3: Estimated Marginal Means (EMM) and standard errors (SE) for head and trunk RMS 
accelerations (adjusted for walking speed and stride time variability) for the PD fallers, PD 
Non-Fallers and age-matched Older Adults while walking on the treadmill at 70%, 100% and 
130% of their preferred walking speed. 
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Fig. 3
 Table 1: Demographic data and disease-specific scores for the participants with PD Fallers, 
PD Non-Fallers and the age-matched Older Adults. Data represent the mean (standard error 
of the mean (SEM)) values or absolute numbers and percentages. Test 1 = one-way ANOVA; 
Test 2 = Kruskal-Wallis Test; Test 3 = χ2 test. 
ns: No significant differences between groups; a: PD Fallers significantly different to PD Non-Fallers; b: PD Fallers 
significantly different to Older Adults; c: PD Non-Fallers significantly different to Older Adults 
       PD Fallers PD Non-
Fallers 
Older 
Adults 
Test Sig 
Demographics      
Age (Years) 69.3 (2.2) 66.5 (2.5) 68.6 (2.8) 1 ns 
Gender (Male) 6 (60.0%) 6 (60.0%) 6 (60.0%) 3 ns 
Height (cm) 165.7 (3.5) 168.5 (3.8) 168.7 (2.7) 1 ns 
Ns 
ns 
Mass (kg) 65.9 (6.2) 67.9 (3.8) 65.9 (3.1) 1 n  
      
Falls History and Fear of Falls      
Activities-Specific Balance Confidence 59.3 (8.9) 78.7 (4.7) 82.3 (7.0) 2 ns 
Previous Falls (12 months) 9.5 (4.8) 0.0 (0.0) 0.4 (0.2) 2 a, b 
      
Quality of Life      
8-item Parkinson’s Disease 
Questionnaire 
28.8 (4.9) 14.4 (2.1)  2 a 
      
Neurological Exam      
Disease Duration (years) 7.0 (1.7) 4.6 (0.6)  2 ns 
Levodopa (mg/day) 810.8 (147.8) 451.6 (102.9)  1 ns 
Dopamine Agonists 2 (20.0%) 2 (20.0%)  3 ns 
Catechol-O-Methyl Transferase 
Inhibitors 
2 (20.0%) 2 (20.0%)  3 ns 
Monoamine Oxidase 6 (60.0%) 3 (30.0%)  3 ns 
Benzodiazepine 0 (0.0%) 0 (0.0%)  3 ns 
No Medication 0 (0.0%) 1 (10.0%)  3 ns 
UPDRS III 22.6 (1.9) 13.1 (2.1)  1 a 
Hoehn & Yahr Stage Score 2.2 (0.2) 1.4 (0.2)  2 a 
Schwab & England ADL Scale 77.0 (2.4) 89.5 (2.0)  1 a 
Revised Freezing of Gait Score 10.8 (3.2) 2.1 (2.1)  2 a 
      
      
 Table 2: Estimated Marginal Means (EMM) and standard errors (SE) for the head and trunk harmonic ratios and RMS accelerations (adjusted for walking speed 
and stride time variability) for the PD fallers, PD Non-Fallers and Older Adults while walking on the treadmill at 70%, 100% and 130% of their preferred walking 
speed. Note: Larger harmonic ratios depict a greater proportion of in-phase relative to out-of-phase accelerations and, hence represent more rhythmic gait patterns. 
      70% Preferred Walking Speed 100% Preferred Walking Speed 130% Preferred Walking Speed  
 PD Fallers PD Non-Fallers Older Adults PD Fallers PD Non-Fallers Older Adults PD Fallers PD Non-Fallers Older Adults Sig 
 EMM (SE) EMM (SE) EMM (SE) EMM (SE) EMM (SE) EMM (SE) EMM (SE) EMM (SE) EMM (SE)  
           
Harmonic Ratios           
 Anteroposterior 1.54 (0.08) 1.69 (0.06) 1.63 (0.06) 1.86 (0.06) 1.75 (0.05) 1.85 (0.06) 1.77 (0.05) 1.93 (0.06) 1.96 (0.07) ¥, §, † 
Head Mediolateral 1.74 (0.08) 2.27 (0.07) 2.84 (0.07) 1.94 (0.06) 2.46 (0.06) 2.95 (0.06) 2.15 (0.06) 2.61 (0.07) 3.15 (0.08) a, b, c, ¥, Ŧ, § 
 Vertical 2.22 (0.10) 2.54 (0.08) 2.75 (0.09) 2.52 (0.08) 2.73 (0.07) 3.19 (0.08) 2.34 (0.08) 2.89 (0.09) 3.40 (0.10) a, b, c, ¥, §, † 
            Anteroposterior 2.08 (0.09) 2.37 (0.08) 2.30 (0.08) 2.15 (0.07) 2.24 (0.07) 2.71 (0.08) 1.68 (0.07) 2.55 (0.08) 2.67 (0.09) a, b, c, ¥, † 
Trunk Mediolateral 1.96 (0.10) 2.14 (0.08) 2.26 (0.09) 2.14 (0.08) 2.24 (0.07) 2.68 (0.08) 2.24 (0.07) 2.56 (0.09) 3.07 (0.10) a, b, c, ¥, Ŧ, §, † 
 Vertical 2.46 (0.12) 2.94 (0.10) 3.02 (0.10) 2.82 (0.10) 3.01 (0.09) 3.53 (0.10) 2.50 (0.09) 3.12 (0.10) 3.77 (0.12) a, b, c, ¥, §, † 
           
RMS Acceleration (m/s2)          
 Anteroposterior 1.17 (0.10) 0.79 (0.10) 0.72 (0.10) 1.09 (0.10) 0.61 (0.10) 0.57 (0.10) 0.88 (0.10) 0.62 (0.10) 0.51 (0.10) a, b, ¥, § 
Head Mediolateral 1.33 (0.11) 0.90 (0.11) 1.02 (0.11) 1.11 (0.11) 0.76 (0.11) 0.83 (0.11) 0.98 (0.11) 0.77 (0.11) 0.78 (0.11) ¥, § 
 Vertical 1.85 (0.12) 1.51 (0.12) 1.41 (0.12) 1.79 (0.12) 1.47 (0.12) 1.52 (0.12) 1.80 (0.12) 1.76 (0.12) 1.78 (0.12) Ŧ, §, † 
            Anteroposterior 1.02 (0.07) 0.78 (0.07) 0.71 (0.07) 0.91 (0.07) 0.79 (0.07) 0.72 (0.07) 0.84 (0.07) 0.91 (0.07) 0.75 (0.07) † 
Trunk Mediolateral 1.66 (0.14) 1.24 (0.14) 1.18 (0.14) 1.39 (0.14) 0.99 (0.14) 0.95 (0.14) 1.16 (0.14) 1.00 (0.14) 0.92 (0.14) ¥, § 
 Vertical 2.05 (0.14) 1.46 (0.14) 1.46 (0.14) 2.03 (0.14) 1.53 (0.14) 1.62 (0.14) 2.04 (0.14) 1.93 (0.14) 1.89 (0.14) Ŧ, §, † 
           
ns: No significant differences between groups; a: PD Fallers significantly different to PD Non-Fallers; b: PD Fallers significantly different to Older Adults; c: PD Non-Fallers significantly 
different to Older Adults; ¥ 70% significantly different to 100%; Ŧ 100% significantly different to 130%; § 70% significantly different to 130%; † significant Group*Speed interaction. 
 
 
 
